Leadership & Pay ·
Lifeward Ltd. announced that President and CEO Mark Grant departed effective August 31, 2026, following a separation…
LFWDLifeward Ltd.
Lifeward Ltd. announced that President and CEO Mark Grant departed effective August 31, 2026, following a separation agreement. His unvested equity awards were forfeited, and he will serve as Senior Advisor through September 30, 2026, for a $40,000 consulting fee without cash severance. The Board appointed Josh Hexter as Interim CEO effective September 1, 2026; Hexter receives a monthly salary of NIS 100,000 plus benefits and will reduce his role at controlling shareholder Oramed Pharmaceuticals to approximately 5% of his time. Additionally, Rami Aviram was appointed CFO effective November 1, 2026, succeeding Almog Adar who departs September 30, 2026; Aviram receives a monthly salary of NIS 70,000 plus benefits. Lifeward Ltd. operates in the life sciences industry, developing medical devices and treatments.